Phase 2 study of SNS-301 in multiple solid tumor indications and hematological malignancies
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2019
Price : $35 *
At a glance
- Drugs SNS 301 (Primary)
- Indications Haematological malignancies; Solid tumours
- Focus Therapeutic Use
- 01 Apr 2019 According to Sensei Biotherapeutics media release, company plnas to start this trial in mid-2019.
- 26 Oct 2018 New trial record
- 19 Oct 2018 According to Sensei Biotherapeutics media release,study is expected to start in early 2019.